Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stryker Aims To Be Greater Than The Sum Of Its Parts

This article was originally published in The Gray Sheet

Executive Summary

Stryker says it is shifting from “fierce decentralization” to more collaboration between business units to offer customers more holistic solutions.

You may also be interested in...

J&J Launches Risk-Sharing Program With Hospitals

Johnson & Johnson recently launched a pilot program consisting of new contracts to share outcome risks with hospitals, CEO Alex Gorsky said during the company’s Jan. 21 earnings call.

News Briefs: FDA Program Alignment Group; CardioMEMS Panel; HCV Coverage Analysis

FDA announces the formation of a new Program Alignment Group, made up of center directors and other officials, and schedules an workshop on intraocular lenses. The agency’s Circulatory System Devices panel will review CardioMEMS’ pulmonary monitoring system again and Medtronic devices. CMS opens coverage analysis for hepatitis C screening. More news.

Stryker Enters China Race With Trauson Bid

The race to acquire a local foothold in China’s medical device industry is on. Stryker's bid to pay $764 million for Trauson Holdings would take out China’s second sizable domestic supplier of orthopedic implants.


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts